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Survivor Turned 
Supporter
Diagnosed with and successfully 
treated for breast cancer at Jefferson 
in 1984, Marianne Connolly 
returned when faced with a potential 
diagnosis of pancreatic cancer in 
2005. Feeling blessed by her 
fortunate outcome and access to 
excellent medical care, Marianne 
and her husband Charles made a 
very personal decision to support 
Jefferson. They decided to contribute 
to research efforts that would 
translate into advanced treatment 
for patients with pancreatic cancer.
The Connollys have pledged 
$100,000 to support Jefferson’s 
cutting edge clinical and investigative 
work in pancreatic cancer and its 
related diseases. Charles J. Yeo, MD, 
Samuel D. Gross Professor and Chair 
of Surgery, leads a multidisciplinary 
team of surgeons, radiologists, and 
gastroenterologists in the new 
Jefferson Pancreatic, Biliary, and 
Related Cancers Center. The 
Connolly gift helps Dr. Yeo and the 
Center pursue research discoveries 
and gain momentum in the ongoing 
fight against these diseases. 
“We feel very fortunate for the 
incredible experience I had at 
Jefferson, most recently under Dr. 
Yeo’s care,” says Marianne. “It is a 
great gift that we can use my 
situation to assist others. By 
supporting Dr. Yeo’s research, we 
are able to turn a negative personal 
situation into something that 
provides hope to many people.” 
“It is truly the generosity and the 
example set forth by the Connollys 
that will provide us with the resources 
necessary to fight this complicated 
disease,” says Assistant Professor 
Jonathan Brody, PhD, who runs a 
laboratory devoted to pancreatic 
cancer in the Division of Surgical 
Research. “With the Connolly’s 
commitment to our pancreatic group 
here at Jefferson, we will be able to 
explore the realistic possibility of 
providing individualized and 
enhanced treatment strategies to 
patients with pancreatic cancer. In 
short, without these resources, many 
of the group’s good ideas would never 
be tested or eventually put into 
practice with patients.”
While the Connolly’s generous 
pledge has made ambitious basic and 
translational pancreatic cancer 
research possible at Jefferson, several 
other fronts still require funding. 
One such project is the Jefferson 
Pancreas Tumor Registry, a 
longitudinal study which aims to arm 
researchers with a better 
understanding of the familial 
components of pancreatic cancer and 
to identify environmental and 
occupational exposures that may 
increase an individual’s risk of 
developing the disease.
For more information, or to  
make a gift to the Department of 
Surgery, please contact Lara Allan 
Goldstein at 215-955-8797 or  
Lara.AllanGoldstein@jefferson.edu. 
David Tichansky, MD
Those Who Give News in Brief 
Marianne and Charles Connelly’s generous contribution to the Jefferson 
Pancreatic, Biliary, and Related Cancers Center is making individualized 
treatment strategies a realistic possibility for future patients.
David Tichansky, MD has joined the 
Division of General Surgery as the 
Director of the Bariatric and Metabolic 
Surgery Program. He specializes in totally 
laparoscopic bariatric surgery and is 
assisted by Alise Kuhl, CRNP-BC. For a 
schedule of free patient seminars, go to 
www.jeffersonhospital.org/bariatric
Susan Lanza-Jacoby, PhD was awarded a R21 NIH grant to study 
different types of calorie restriction on the progression of PanIN 
lesions to Pancreatic Ductal Adenocarcinoma (PDA). 
Gerald A. Isenberg, MD and the Department of Surgery are co-
investigators in a NIH study of Wise-MD, a web based multimedia 
teaching tool for surgical students created by New York University. 
John Kairys, MD is a Co-Investigator on a Department of Defense 
grant entitled, “3D Projection Environment for Molecular Design 
and Surgical Simulation.” Eric Wickstrom, PhD, Professor of 
Biochemistry and Molecular Biology, is the Principal Investigator.
Sharon Molotsky, RN, BSN, CCRC has been promoted to the newly 
created position of Clinical Research Nurse Project Manager for the 
Department of Surgery.
Paul J. DiMuzio, MD, PhD, was awarded first place for his 
presentation, “Endothelial differentiation of adipose-derived 
stem cells: How close have we really come?”, at the International 
Federation for Adipose Therapeutics and Science (IFATS) 
Conference, September 2009 in Toulouse, France. 
May 31st marks the 25th anniversary of the first liver transplant 
in the Delaware Valley performed at Jefferson. A celebratory 
reception for liver transplant patients and families is planned for 
Tuesday, May 5, 2009.
Save the Date: The Investiture of Cataldo Doria, MD, PhD  
as the first Nicoletti Family Professor of Transplantation Surgery 
will be held on June 17, 2009 at 4 p.m. in  Connelly Auditorium, 
Dorrance H. Hamilton Building. Please contact Lara Allan Goldstein 
at 215-955-8797 if interested in attending.
 
THOMAS JEFFERSON UNIVERSITY AND HOSPITALS
When Florence Jackson, 73, had some 
difficulty swallowing her food one evening, 
her husband insisted she see her doctor. 
She mentioned it at her six-month check-
up, and notes that years earlier she had 
suffered from acid reflux, which is known 
to be a possible cause of esophageal 
cancer. A barium swallow test revealed an 
obstruction in her esophagus. 
In southern Delaware, where Florence 
lives, there was no facility that could do an 
endoscopic ultrasound. She was referred 
to Jefferson, where she was treated by 
Ernest (Gary) Rosato, MD, Director of the 
General Surgery Division, and Associate 
Professor Benny Weksler, MD, MBA, a 
thoracic surgeon. She was diagnosed with 
Stage 2A cancer of the esophagus, but the 
team offered her an excellent treatment 
plan. Prior to any surgery, Florence 
underwent chemotherapy and radiation 
therapy at the Tunnel Cancer Center in 
Delaware to shrink the tumor as much as 
possible. Then, at Jefferson, she underwent 
a laparoscopic esophagectomy, which is 
an innovative, minimally invasive surgery 
with a relatively short recovery. 
Jefferson is the only area hospital offering a 
unique team approach which provides the 
patient with the expertise of two surgeons 
trained in minimally invasive surgery 
(MIS). Dr. Weksler operates on the part of 
the esophagus in the chest and Dr. Rosato 
operates on the portion in the abdomen.
“My experience with Jefferson was none 
other than outstanding,” says Florence. 
“In addition to the kindness and respect 
for me as an individual, it was a great 
comfort to have such an experienced, 
compassionate team with a successful track 
record.” Florence’s stay in the hospital was 
only 11 days, and she was pleased that she 
was “back to normal” within just 10 days 
of returning home.
Jefferson is also the only hospital in the 
Philadelphia region performing a high 
volume of laparoscopic esophagectomies—
25 during 2008, and the Department 
expects to double that number in 2009. 
A study of those cases demonstrates a 
decrease in morbidity over open surgeries. 
Dr. Rosato explains the benefits of this 
procedure: “With conventional ‘open’ 
surgeries, the incisions are large and painful, 
and the hospital stay is longer,” he says. 
“Laparoscopic surgery results in shorter 
recovery and patient hospitalization.”
Minimally Invasive and Robotic General 
Surgery an Option for More Patients
Dr. Ernest (Gary) Rosato, Director of the General Surgery Division, and Florence Jackson are pleased 
with her quick recovery and good prognosis following a minimally invasive esophagectomy to treat 
Stage 2A esophageal cancer.
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Dr. Benny Weksler, who is Board 
Certified in Surgery and Thoracic 
Surgery, is a leader in the innovative 
technique of robotic surgery. “Like 
laparoscopic surgery, “Dr. Weksler 
explains, “robotic surgery is done via 
only a few small incisions. However, 
instead of holding the surgical 
instruments, the surgeon sits at a 
control panel and utilizes robotic arms 
to move the instruments.” He notes 
that robotic surgery is far safer because 
it offers greater precision, smaller 
incisions, decreased blood loss, and less 
pain for the patient.
The only robotic system approved by 
the Food and Drug Administration is 
the da Vinci® Surgical System, named 
after the famous artist who invented the 
first robot. “We are the only facility in 
Philadelphia using robotic surgery for 
thoracic operations,” says Dr. Weksler.  
In 2008, Jefferson performed seven 
operations utilizing this exciting new 
technology. That number will increase 
in 2009 and already includes four robot-
assisted esophagectomies for patients 
like Florence Jackson.
Benny Weksler, MD, MBA 
Director, Minimally Invasive and 
Robotic Thoracic Surgery Program
The Surgeon Speaks
Dr. Rosato also emphasizes Jefferson’s 
commitment to the latest training and 
technology. “We have steadily increased 
our volume of minimal invasive surgeries 
over the last four years,” he explains, “and 
we are now training residents and a fellow 
in the specialty.” Jooyeun Chung, MD, 
the current Minimally Invasive Surgery 
Fellow and a graduate of Jefferson’s 
residency program, has already built 
an impressive record with more than 
30 minimally invasive surgeries for the 
esophagus. “We are aggressively taking 
the lead by developing one of the most 
experienced MIS/GI/Thoracic capabilities 
in Philadelphia,” says Dr. Rosato, “and 
are setting the tone and pace for what will 
become the future of general surgery.”
For more information about  
Minimally Invasive Surgery visit: 
www.jeffersonhospital.org/keyhole
Jefferson is also the only hospital 
in the Philadelphia region 
performing a high volume of 
laparoscopic esophagectomies...
“It is truly the generosity 
and the example set forth 
by the Connollys that 
will provide us with the 
resources necessary to fight 
this complicated disease”
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Samuel D. Gross Professor and  
Chair, Department of Surgery
The Spring of 2009 represents an exciting 
time here in the Department of Surgery. 
Despite the turbulent economic times, 
our clinical footprint has grown nicely, 
averaging a 5 to 12% increase per year for 
the last three years. Newer programs such 
as our minimally invasive esophagectomy 
and pancreatectomy programs, our 
bariatric surgery program, our mechanical 
heart support program, and our thriving 
acute care surgery (and intensivist) 
program are examples of success stories.
We have received good news on the 
research front. Our residents and faculty 
just completed a very busy Fall and Winter, 
when well over a dozen presentations were 
made at national fora, such as the Southern 
Surgical, the 4th Academic Surgical 
Congress, the Southeastern Surgical, and 
the American Hepato-Pancreato-Biliary 
Association, amongst others. Additionally, 
we are delighted to have recently been 
notified of major grant awards to Drs. 
Lanza-Jacoby and Tulenko, representing 
NIH dollars into the Department. Our clinical 
research has grown nicely, and the addition 
of Sharon Molotsky, RN, BSN, CCRC as our 
Clinical Research Nurse Project Manager 
will do much to ensure the attention to 
detail needed for our clinical trials.
My thanks go out to all members of the 
Department for their enthusiasm, hard 
work, clinical expertise and academic 
performance over the last several years. 
It has been wonderful to see Jefferson’s 
stature rise amongst other academic 
medical centers, as we have added faculty, 
increased our clinical volumes, added 
new clinical programs, and raised the 
research profile (both for our basic science 
researchers and for our clinicians).
New faculty, upgrades to the Intensive 
Care Unit (ICU), and multiple new trials 
and studies are just some of the changes 
underway in the Acute Care Surgery 
Division. The addition of Jay Jenoff, MD, 
and Niels Martin, MD, brings the Division 
team to seven faculty, strengthening its 
intensivist program, which makes an 
attending acute care surgeon available 24 
hours a day, 7 days a week.
Drs. Jenoff and Martin recently joined 
the Division after completing Fellowships in 
Traumatology and Surgical Critical Care at 
the Hospital of The University of 
Pennsylvania. Dr. Jenoff, Assistant Professor 
of Surgery and a 2005 graduate of the 
Jefferson Surgery residency program, is 
Board Certified in both surgery and critical 
care medicine. Dr. Martin, a 2006 graduate 
of Jefferson’s residency program is also 
Board Certified in surgery and critical care 
medicine and has been named the Associate 
Program Director of Graduate Education.
As part of Jefferson’s commitment to 
continually improving the care and 
experience of patients, the hospital is 
building a new, state-of-the-art ICU facility 
in the Gibbon Building on Jefferson’s 
Center City campus. Construction is 
expected to be completed during this year 
and will add to the existing ICU. The new 
space will accommodate 34 beds, half of 
which will be dedicated to surgical patients. 
“This fully functional ICU will have the 
most advanced technology, tools and 
instruments available,” says Dr. Martin, “so 
that we can respond to a patient’s needs, 
from pre- and post-operative care to 
bedside procedures, under ideal conditions 
with the optimal equipment.”
“Like any professional team, each 
member plays an important role,” says Dr. 
Acute Care Surgery Expands  
its Faculty, Facilities & Research
Residency Program graduates, Drs. Jay Jenoff and Niels Martin, have returned to Jefferson  
as Assistant Professors in the Acute Care Surgery Division.
Overview Clinical Integration
Dr. Joshua Curtin in the  
New Transplant Laboratory
Joshua Curtin, PhD, is a 
research fellow in the lab 
of Cataldo Doria, MD, PhD, 
focusing on the regulation 
of tumor cell growth and 
division, primarily in the liver.  
He examines how molecular 
components of cellular signaling 
pathways function to regulate 
cell growth and cell death. 
Dr. Curtin’s doctoral research studied the 
actions of natural derivatives of Vitamin A 
known as tumor cell differentiators. Derivatives 
of Vitamin A are a class of compounds known 
as retinoids, which have been shown to  
prevent the unchecked division of cancer  
cells. “Although traditional chemotherapies  
kill both the mutated cancer cells and the 
healthy normal cells,” Dr. Curtin explains,  
“this treatment stops only the cancer cells  
from dividing.”
Please Welcome
Dr. Curtin has coupled his expertise as  
a cancer biologist with his experience  
as a post-doctoral fellow in liver biology.  
“The ultimate goal,” he explains, “is to 
translate discovery in the lab into improved 
clinical treatment for patients suffering  
from liver cancer.”
To read more about this research, go to  
www.jeffersonhospital.org/transplant
Jenoff, “and our two trauma nurse 
practitioners, Alannah Ryan, CRNP, and 
Catherine Gill-Preston, CRNP, are 
absolutely invaluable to the doctors and 
patients. Their case management skills, 
skill level, and compassion for patients are 
second-to-none.”
In addition to clinical priorities, the 
Division is placing a renewed emphasis on 
research and has recently undertaken 
several clinical trials and studies. “A 
number of these new studies make 
Jefferson—and our Division in 
particular—an exciting place to be right 
now, a place to grow as a professional,” 
says Dr. Martin. In trauma, for example, 
the group is looking at new methods of 
stabilization, prevention studies, and 
resuscitation. Faculty members are also 
studying abdominal wall outcomes and 
developing new protocols, while working 
with industry representatives on device 
implementation. Research projects include 
multidisciplinary collaborations with 
Jefferson colleagues in rehabilitation and 
orthopedics. Over the next 12–15 months 
Division faculty will present findings at 
multiple national academic meetings.
For more information about the Acute Care 
Surgery Division, visit their new website at  
www.jefferson.edu/acutecare
Surgical Residents Make 
Significant Contributions to 
Ongoing Cancer Research
The Department of Surgery’s research 
efforts have expanded greatly in recent 
years as evidenced by the breadth and 
depth of resident research projects. 
Dr. L. Andrew Shirley spent two years 
in the laboratory and was the Principal 
Investigator of a study analyzing the role of 
the Dachshund (DACH1) cell fate 
determination pathway in various cancer 
types, including breast, prostate, colorectal, 
and pancreatic cancers. The study, funded 
by a Radiation Therapy Oncology Group 
Translational Research Program seed 
grant, was conducted under the 
mentorship of Richard Pestell, MD, PhD, 
Director of the Kimmel Cancer Center. Dr. 
Shirley presented the findings at the 3rd 
Annual Academic Surgical Congress and 
in four peer-reviewed articles. 
Jonathan Brody, PhD, a specialist in 
pancreatic cancer research has mentored 
several residents in his laboratory.  
Dr. Shayna Showalter explored targets  
in pancreatic cancer to develop novel 
therapeutic strategies and examined the 
effect of naturally occurring Vitamin K on 
pancreatic cancer cells. She found that 
Vitamin K actually inhibits pancreatic 
cancer cell growth. Dr. Showalter also used 
novel nanoparticle technology to deliver 
diphtheria toxin specifically to pancreatic 
cancer cells, therefore killing the cancer 
cells without effecting the growth of 
normal, noncancer cells. To date, she has 
presented the findings at three meetings, 
including the American Association for 
Cancer Research Annual Meeting, and in 
three peer-reviewed articles.
Also under Dr. Brody’s mentorship,  
Dr. Timothy Williams investigated the 
tumor suppressor protein pp32 and its role 
in pancreatic tumor development. The 
research established that pp32 is low or 
absent in poorly differentiated pancreatic 
cancer, it suppresses tumor growth when 
its expression is restored, and impacts the 
response of cancer cells to certain 
chemotherapy drugs commonly used to 
treat pancreatic cancer. To date, Dr. 
Williams has published three peer-
reviewed publications on this research, 
presented posters at three meetings and 
shares the Award for Best Research 
Presentation in the Department of Surgery. 
Dr. Nikolai Bildzukewicz is continuing 
the work established by Dr. Williams on 
the role of pp32 in a drug resistance 
pathway. However, his primary research 
focuses on Poly(ADP Ribose) Polymerase-
1 (PARP-1), an enzyme found within the 
cell nucleus that serves many cellular 
functions including repair of damaged 
DNA. In collaboration with John Pascal, 
PhD, Assistant Professor of Biochemistry 
and Molecular Biology, Dr. Bildzukewicz 
is working with both normal and mutant 
forms of the enzyme in pancreatic cancer 
cells. His findings include the concept of 
using novel agents, PARP-inhibitors, to 
sensitize pancreatic cancer cells to 
platinum-based FDA-approved drugs. 
This work provides the proof-of-principle 
data for a proposed clinical trial. Dr. 
Bildzukewicz presented the initial findings 
to the Philadelphia Academy of Surgery 
meeting in February 2008. 
In Dr. Susan Lanza-Jacoby’s laboratory, 
Dr. Matthew Rosen is studying the effect 
of Nexrutine, a natural Cox-2 inhibitor on 
pancreatic cancer cells, and the 
relationship of sirtuin (a protein involved 
in improving health during calorie 
restriction) to pancreatic cancer. Dr. 
Rosen has already presented findings at 
two meetings including the American 
Association of Cancer Research. Dr. 
Rosen is also the recipient of the Arnold 
P. Gold Foundation Humanism and 
Excellence in Teaching Award.
In Dr. Hwyda Arafat’s laboratory,  
Dr. Jennifer Sullivan is analyzing how 
nictotine exposure contributes to the 
aggressive nature of pancreatic cancer. 
Her research focuses on the expression of 
a protein, Osteopontin-C, which appears 
to be increased in patients with pancreatic 
cancer, especially those with a history of 
smoking. This protein could be a potential 
target for future therapy. Dr. Sullivan 
recently presented her data at the 
Academic Surgical Congress and a 
manuscript has been accepted for 
publication in Surgery.
Zi-Xuan (Zoe) Wang, PhD
Zi-XuanWang, PhD, is an Assistant 
Professor of Surgery, with a secondary 
appointment in the Department 
of Pathology, Anatomy, and Cell 
Biology, where she is the Assistant 
Director of the Clinical Microbiology 
Laboratory. She joined Jefferson in 
October 2008 after six years at the 
Medical College of Georgia where 
she was the Scientific Director of the 
Molecular Diagnostics Laboratory.
What is the focus of your research?
My passion is personalized medicine: 
to find out how and why certain 
therapies/medicines do or do 
not work and then to develop a 
customized approach to enhance a 
patient’s treatment. Since people can 
metabolize or respond to medicines 
in various ways, genetic analysis can 
predict a certain patient’s response, so 
that therapeutics can be administered 
and dosed optimally.
How do you use technology in  
your work?
DNA sequencing and gene chips  
have made testing individuals feasible. 
We characterize specific aspects of 
cancer and host genomes to predict 
whether a drug will be effective 
or whether serious side effects 
will emerge. Characterization of 
mutations in the patient’s genome can 
predict drug resistance and provide a 
personalized approach.
What motivates you on a day-to- 
day basis?
As a scientist, I am dedicated to 
improving the health of human 
beings and I especially enjoy working 
with the surgical faculty on pancreatic 
cancer and translational research. 
As a team, our analytical skills and 
emerging technologies have pushed 
us to the leading edge of diagnostics. 
Future collaborations with other 
Jefferson researchers will further 
advance our progress and ultimately 
improve medicine. 
Drs. Shayna Showalter, Matthew Rosen, L. Andrew Shirley, Nikolai Bildzukewicz,  
Jennifer Sullivan and Timothy Williams have made impressive contributions to cancer 
research at Jefferson as part of their surgical residency training.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research On the Job
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Chair, Department of Surgery
The Spring of 2009 represents an exciting 
time here in the Department of Surgery. 
Despite the turbulent economic times, 
our clinical footprint has grown nicely, 
averaging a 5 to 12% increase per year for 
the last three years. Newer programs such 
as our minimally invasive esophagectomy 
and pancreatectomy programs, our 
bariatric surgery program, our mechanical 
heart support program, and our thriving 
acute care surgery (and intensivist) 
program are examples of success stories.
We have received good news on the 
research front. Our residents and faculty 
just completed a very busy Fall and Winter, 
when well over a dozen presentations were 
made at national fora, such as the Southern 
Surgical, the 4th Academic Surgical 
Congress, the Southeastern Surgical, and 
the American Hepato-Pancreato-Biliary 
Association, amongst others. Additionally, 
we are delighted to have recently been 
notified of major grant awards to Drs. 
Lanza-Jacoby and Tulenko, representing 
NIH dollars into the Department. Our clinical 
research has grown nicely, and the addition 
of Sharon Molotsky, RN, BSN, CCRC as our 
Clinical Research Nurse Project Manager 
will do much to ensure the attention to 
detail needed for our clinical trials.
My thanks go out to all members of the 
Department for their enthusiasm, hard 
work, clinical expertise and academic 
performance over the last several years. 
It has been wonderful to see Jefferson’s 
stature rise amongst other academic 
medical centers, as we have added faculty, 
increased our clinical volumes, added 
new clinical programs, and raised the 
research profile (both for our basic science 
researchers and for our clinicians).
New faculty, upgrades to the Intensive 
Care Unit (ICU), and multiple new trials 
and studies are just some of the changes 
underway in the Acute Care Surgery 
Division. The addition of Jay Jenoff, MD, 
and Niels Martin, MD, brings the Division 
team to seven faculty, strengthening its 
intensivist program, which makes an 
attending acute care surgeon available 24 
hours a day, 7 days a week.
Drs. Jenoff and Martin recently joined 
the Division after completing Fellowships in 
Traumatology and Surgical Critical Care at 
the Hospital of The University of 
Pennsylvania. Dr. Jenoff, Assistant Professor 
of Surgery and a 2005 graduate of the 
Jefferson Surgery residency program, is 
Board Certified in both surgery and critical 
care medicine. Dr. Martin, a 2006 graduate 
of Jefferson’s residency program is also 
Board Certified in surgery and critical care 
medicine and has been named the Associate 
Program Director of Graduate Education.
As part of Jefferson’s commitment to 
continually improving the care and 
experience of patients, the hospital is 
building a new, state-of-the-art ICU facility 
in the Gibbon Building on Jefferson’s 
Center City campus. Construction is 
expected to be completed during this year 
and will add to the existing ICU. The new 
space will accommodate 34 beds, half of 
which will be dedicated to surgical patients. 
“This fully functional ICU will have the 
most advanced technology, tools and 
instruments available,” says Dr. Martin, “so 
that we can respond to a patient’s needs, 
from pre- and post-operative care to 
bedside procedures, under ideal conditions 
with the optimal equipment.”
“Like any professional team, each 
member plays an important role,” says Dr. 
Acute Care Surgery Expands  
its Faculty, Facilities & Research
Residency Program graduates, Drs. Jay Jenoff and Niels Martin, have returned to Jefferson  
as Assistant Professors in the Acute Care Surgery Division.
Overview Clinical Integration
Dr. Joshua Curtin in the  
New Transplant Laboratory
Joshua Curtin, PhD, is a 
research fellow in the lab 
of Cataldo Doria, MD, PhD, 
focusing on the regulation 
of tumor cell growth and 
division, primarily in the liver.  
He examines how molecular 
components of cellular signaling 
pathways function to regulate 
cell growth and cell death. 
Dr. Curtin’s doctoral research studied the 
actions of natural derivatives of Vitamin A 
known as tumor cell differentiators. Derivatives 
of Vitamin A are a class of compounds known 
as retinoids, which have been shown to  
prevent the unchecked division of cancer  
cells. “Although traditional chemotherapies  
kill both the mutated cancer cells and the 
healthy normal cells,” Dr. Curtin explains,  
“this treatment stops only the cancer cells  
from dividing.”
Please Welcome
Dr. Curtin has coupled his expertise as  
a cancer biologist with his experience  
as a post-doctoral fellow in liver biology.  
“The ultimate goal,” he explains, “is to 
translate discovery in the lab into improved 
clinical treatment for patients suffering  
from liver cancer.”
To read more about this research, go to  
www.jeffersonhospital.org/transplant
Jenoff, “and our two trauma nurse 
practitioners, Alannah Ryan, CRNP, and 
Catherine Gill-Preston, CRNP, are 
absolutely invaluable to the doctors and 
patients. Their case management skills, 
skill level, and compassion for patients are 
second-to-none.”
In addition to clinical priorities, the 
Division is placing a renewed emphasis on 
research and has recently undertaken 
several clinical trials and studies. “A 
number of these new studies make 
Jefferson—and our Division in 
particular—an exciting place to be right 
now, a place to grow as a professional,” 
says Dr. Martin. In trauma, for example, 
the group is looking at new methods of 
stabilization, prevention studies, and 
resuscitation. Faculty members are also 
studying abdominal wall outcomes and 
developing new protocols, while working 
with industry representatives on device 
implementation. Research projects include 
multidisciplinary collaborations with 
Jefferson colleagues in rehabilitation and 
orthopedics. Over the next 12–15 months 
Division faculty will present findings at 
multiple national academic meetings.
For more information about the Acute Care 
Surgery Division, visit their new website at  
www.jefferson.edu/acutecare
Surgical Residents Make 
Significant Contributions to 
Ongoing Cancer Research
The Department of Surgery’s research 
efforts have expanded greatly in recent 
years as evidenced by the breadth and 
depth of resident research projects. 
Dr. L. Andrew Shirley spent two years 
in the laboratory and was the Principal 
Investigator of a study analyzing the role of 
the Dachshund (DACH1) cell fate 
determination pathway in various cancer 
types, including breast, prostate, colorectal, 
and pancreatic cancers. The study, funded 
by a Radiation Therapy Oncology Group 
Translational Research Program seed 
grant, was conducted under the 
mentorship of Richard Pestell, MD, PhD, 
Director of the Kimmel Cancer Center. Dr. 
Shirley presented the findings at the 3rd 
Annual Academic Surgical Congress and 
in four peer-reviewed articles. 
Jonathan Brody, PhD, a specialist in 
pancreatic cancer research has mentored 
several residents in his laboratory.  
Dr. Shayna Showalter explored targets  
in pancreatic cancer to develop novel 
therapeutic strategies and examined the 
effect of naturally occurring Vitamin K on 
pancreatic cancer cells. She found that 
Vitamin K actually inhibits pancreatic 
cancer cell growth. Dr. Showalter also used 
novel nanoparticle technology to deliver 
diphtheria toxin specifically to pancreatic 
cancer cells, therefore killing the cancer 
cells without effecting the growth of 
normal, noncancer cells. To date, she has 
presented the findings at three meetings, 
including the American Association for 
Cancer Research Annual Meeting, and in 
three peer-reviewed articles.
Also under Dr. Brody’s mentorship,  
Dr. Timothy Williams investigated the 
tumor suppressor protein pp32 and its role 
in pancreatic tumor development. The 
research established that pp32 is low or 
absent in poorly differentiated pancreatic 
cancer, it suppresses tumor growth when 
its expression is restored, and impacts the 
response of cancer cells to certain 
chemotherapy drugs commonly used to 
treat pancreatic cancer. To date, Dr. 
Williams has published three peer-
reviewed publications on this research, 
presented posters at three meetings and 
shares the Award for Best Research 
Presentation in the Department of Surgery. 
Dr. Nikolai Bildzukewicz is continuing 
the work established by Dr. Williams on 
the role of pp32 in a drug resistance 
pathway. However, his primary research 
focuses on Poly(ADP Ribose) Polymerase-
1 (PARP-1), an enzyme found within the 
cell nucleus that serves many cellular 
functions including repair of damaged 
DNA. In collaboration with John Pascal, 
PhD, Assistant Professor of Biochemistry 
and Molecular Biology, Dr. Bildzukewicz 
is working with both normal and mutant 
forms of the enzyme in pancreatic cancer 
cells. His findings include the concept of 
using novel agents, PARP-inhibitors, to 
sensitize pancreatic cancer cells to 
platinum-based FDA-approved drugs. 
This work provides the proof-of-principle 
data for a proposed clinical trial. Dr. 
Bildzukewicz presented the initial findings 
to the Philadelphia Academy of Surgery 
meeting in February 2008. 
In Dr. Susan Lanza-Jacoby’s laboratory, 
Dr. Matthew Rosen is studying the effect 
of Nexrutine, a natural Cox-2 inhibitor on 
pancreatic cancer cells, and the 
relationship of sirtuin (a protein involved 
in improving health during calorie 
restriction) to pancreatic cancer. Dr. 
Rosen has already presented findings at 
two meetings including the American 
Association of Cancer Research. Dr. 
Rosen is also the recipient of the Arnold 
P. Gold Foundation Humanism and 
Excellence in Teaching Award.
In Dr. Hwyda Arafat’s laboratory,  
Dr. Jennifer Sullivan is analyzing how 
nictotine exposure contributes to the 
aggressive nature of pancreatic cancer. 
Her research focuses on the expression of 
a protein, Osteopontin-C, which appears 
to be increased in patients with pancreatic 
cancer, especially those with a history of 
smoking. This protein could be a potential 
target for future therapy. Dr. Sullivan 
recently presented her data at the 
Academic Surgical Congress and a 
manuscript has been accepted for 
publication in Surgery.
Zi-Xuan (Zoe) Wang, PhD
Zi-XuanWang, PhD, is an Assistant 
Professor of Surgery, with a secondary 
appointment in the Department 
of Pathology, Anatomy, and Cell 
Biology, where she is the Assistant 
Director of the Clinical Microbiology 
Laboratory. She joined Jefferson in 
October 2008 after six years at the 
Medical College of Georgia where 
she was the Scientific Director of the 
Molecular Diagnostics Laboratory.
What is the focus of your research?
My passion is personalized medicine: 
to find out how and why certain 
therapies/medicines do or do 
not work and then to develop a 
customized approach to enhance a 
patient’s treatment. Since people can 
metabolize or respond to medicines 
in various ways, genetic analysis can 
predict a certain patient’s response, so 
that therapeutics can be administered 
and dosed optimally.
How do you use technology in  
your work?
DNA sequencing and gene chips  
have made testing individuals feasible. 
We characterize specific aspects of 
cancer and host genomes to predict 
whether a drug will be effective 
or whether serious side effects 
will emerge. Characterization of 
mutations in the patient’s genome can 
predict drug resistance and provide a 
personalized approach.
What motivates you on a day-to- 
day basis?
As a scientist, I am dedicated to 
improving the health of human 
beings and I especially enjoy working 
with the surgical faculty on pancreatic 
cancer and translational research. 
As a team, our analytical skills and 
emerging technologies have pushed 
us to the leading edge of diagnostics. 
Future collaborations with other 
Jefferson researchers will further 
advance our progress and ultimately 
improve medicine. 
Drs. Shayna Showalter, Matthew Rosen, L. Andrew Shirley, Nikolai Bildzukewicz,  
Jennifer Sullivan and Timothy Williams have made impressive contributions to cancer 
research at Jefferson as part of their surgical residency training.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research On the Job
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Survivor Turned 
Supporter
Diagnosed with and successfully 
treated for breast cancer at Jefferson 
in 1984, Marianne Connolly 
returned when faced with a potential 
diagnosis of pancreatic cancer in 
2005. Feeling blessed by her 
fortunate outcome and access to 
excellent medical care, Marianne 
and her husband Charles made a 
very personal decision to support 
Jefferson. They decided to contribute 
to research efforts that would 
translate into advanced treatment 
for patients with pancreatic cancer.
The Connollys have pledged 
$100,000 to support Jefferson’s 
cutting edge clinical and investigative 
work in pancreatic cancer and its 
related diseases. Charles J. Yeo, MD, 
Samuel D. Gross Professor and Chair 
of Surgery, leads a multidisciplinary 
team of surgeons, radiologists, and 
gastroenterologists in the new 
Jefferson Pancreatic, Biliary, and 
Related Cancers Center. The 
Connolly gift helps Dr. Yeo and the 
Center pursue research discoveries 
and gain momentum in the ongoing 
fight against these diseases. 
“We feel very fortunate for the 
incredible experience I had at 
Jefferson, most recently under Dr. 
Yeo’s care,” says Marianne. “It is a 
great gift that we can use my 
situation to assist others. By 
supporting Dr. Yeo’s research, we 
are able to turn a negative personal 
situation into something that 
provides hope to many people.” 
“It is truly the generosity and the 
example set forth by the Connollys 
that will provide us with the resources 
necessary to fight this complicated 
disease,” says Assistant Professor 
Jonathan Brody, PhD, who runs a 
laboratory devoted to pancreatic 
cancer in the Division of Surgical 
Research. “With the Connolly’s 
commitment to our pancreatic group 
here at Jefferson, we will be able to 
explore the realistic possibility of 
providing individualized and 
enhanced treatment strategies to 
patients with pancreatic cancer. In 
short, without these resources, many 
of the group’s good ideas would never 
be tested or eventually put into 
practice with patients.”
While the Connolly’s generous 
pledge has made ambitious basic and 
translational pancreatic cancer 
research possible at Jefferson, several 
other fronts still require funding. 
One such project is the Jefferson 
Pancreas Tumor Registry, a 
longitudinal study which aims to arm 
researchers with a better 
understanding of the familial 
components of pancreatic cancer and 
to identify environmental and 
occupational exposures that may 
increase an individual’s risk of 
developing the disease.
For more information, or to  
make a gift to the Department of 
Surgery, please contact Lara Allan 
Goldstein at 215-955-8797 or  
Lara.AllanGoldstein@jefferson.edu. 
David Tichansky, MD
Those Who Give News in Brief 
Marianne and Charles Connelly’s generous contribution to the Jefferson 
Pancreatic, Biliary, and Related Cancers Center is making individualized 
treatment strategies a realistic possibility for future patients.
David Tichansky, MD has joined the 
Division of General Surgery as the 
Director of the Bariatric and Metabolic 
Surgery Program. He specializes in totally 
laparoscopic bariatric surgery and is 
assisted by Alise Kuhl, CRNP-BC. For a 
schedule of free patient seminars, go to 
www.jeffersonhospital.org/bariatric
Susan Lanza-Jacoby, PhD was awarded a R21 NIH grant to study 
different types of calorie restriction on the progression of PanIN 
lesions to Pancreatic Ductal Adenocarcinoma (PDA). 
Gerald A. Isenberg, MD and the Department of Surgery are co-
investigators in a NIH study of Wise-MD, a web based multimedia 
teaching tool for surgical students created by New York University. 
John Kairys, MD is a Co-Investigator on a Department of Defense 
grant entitled, “3D Projection Environment for Molecular Design 
and Surgical Simulation.” Eric Wickstrom, PhD, Professor of 
Biochemistry and Molecular Biology, is the Principal Investigator.
Sharon Molotsky, RN, BSN, CCRC has been promoted to the newly 
created position of Clinical Research Nurse Project Manager for the 
Department of Surgery.
Paul J. DiMuzio, MD, PhD, was awarded first place for his 
presentation, “Endothelial differentiation of adipose-derived 
stem cells: How close have we really come?”, at the International 
Federation for Adipose Therapeutics and Science (IFATS) 
Conference, September 2009 in Toulouse, France. 
May 31st marks the 25th anniversary of the first liver transplant 
in the Delaware Valley performed at Jefferson. A celebratory 
reception for liver transplant patients and families is planned for 
Tuesday, May 5, 2009.
Save the Date: The Investiture of Cataldo Doria, MD, PhD  
as the first Nicoletti Family Professor of Transplantation Surgery 
will be held on June 17, 2009 at 4 p.m. in  Connelly Auditorium, 
Dorrance H. Hamilton Building. Please contact Lara Allan Goldstein 
at 215-955-8797 if interested in attending.
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When Florence Jackson, 73, had some 
difficulty swallowing her food one evening, 
her husband insisted she see her doctor. 
She mentioned it at her six-month check-
up, and notes that years earlier she had 
suffered from acid reflux, which is known 
to be a possible cause of esophageal 
cancer. A barium swallow test revealed an 
obstruction in her esophagus. 
In southern Delaware, where Florence 
lives, there was no facility that could do an 
endoscopic ultrasound. She was referred 
to Jefferson, where she was treated by 
Ernest (Gary) Rosato, MD, Director of the 
General Surgery Division, and Associate 
Professor Benny Weksler, MD, MBA, a 
thoracic surgeon. She was diagnosed with 
Stage 2A cancer of the esophagus, but the 
team offered her an excellent treatment 
plan. Prior to any surgery, Florence 
underwent chemotherapy and radiation 
therapy at the Tunnel Cancer Center in 
Delaware to shrink the tumor as much as 
possible. Then, at Jefferson, she underwent 
a laparoscopic esophagectomy, which is 
an innovative, minimally invasive surgery 
with a relatively short recovery. 
Jefferson is the only area hospital offering a 
unique team approach which provides the 
patient with the expertise of two surgeons 
trained in minimally invasive surgery 
(MIS). Dr. Weksler operates on the part of 
the esophagus in the chest and Dr. Rosato 
operates on the portion in the abdomen.
“My experience with Jefferson was none 
other than outstanding,” says Florence. 
“In addition to the kindness and respect 
for me as an individual, it was a great 
comfort to have such an experienced, 
compassionate team with a successful track 
record.” Florence’s stay in the hospital was 
only 11 days, and she was pleased that she 
was “back to normal” within just 10 days 
of returning home.
Jefferson is also the only hospital in the 
Philadelphia region performing a high 
volume of laparoscopic esophagectomies—
25 during 2008, and the Department 
expects to double that number in 2009. 
A study of those cases demonstrates a 
decrease in morbidity over open surgeries. 
Dr. Rosato explains the benefits of this 
procedure: “With conventional ‘open’ 
surgeries, the incisions are large and painful, 
and the hospital stay is longer,” he says. 
“Laparoscopic surgery results in shorter 
recovery and patient hospitalization.”
Minimally Invasive and Robotic General 
Surgery an Option for More Patients
Dr. Ernest (Gary) Rosato, Director of the General Surgery Division, and Florence Jackson are pleased 
with her quick recovery and good prognosis following a minimally invasive esophagectomy to treat 
Stage 2A esophageal cancer.
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Dr. Benny Weksler, who is Board 
Certified in Surgery and Thoracic 
Surgery, is a leader in the innovative 
technique of robotic surgery. “Like 
laparoscopic surgery, “Dr. Weksler 
explains, “robotic surgery is done via 
only a few small incisions. However, 
instead of holding the surgical 
instruments, the surgeon sits at a 
control panel and utilizes robotic arms 
to move the instruments.” He notes 
that robotic surgery is far safer because 
it offers greater precision, smaller 
incisions, decreased blood loss, and less 
pain for the patient.
The only robotic system approved by 
the Food and Drug Administration is 
the da Vinci® Surgical System, named 
after the famous artist who invented the 
first robot. “We are the only facility in 
Philadelphia using robotic surgery for 
thoracic operations,” says Dr. Weksler.  
In 2008, Jefferson performed seven 
operations utilizing this exciting new 
technology. That number will increase 
in 2009 and already includes four robot-
assisted esophagectomies for patients 
like Florence Jackson.
Benny Weksler, MD, MBA 
Director, Minimally Invasive and 
Robotic Thoracic Surgery Program
The Surgeon Speaks
Dr. Rosato also emphasizes Jefferson’s 
commitment to the latest training and 
technology. “We have steadily increased 
our volume of minimal invasive surgeries 
over the last four years,” he explains, “and 
we are now training residents and a fellow 
in the specialty.” Jooyeun Chung, MD, 
the current Minimally Invasive Surgery 
Fellow and a graduate of Jefferson’s 
residency program, has already built 
an impressive record with more than 
30 minimally invasive surgeries for the 
esophagus. “We are aggressively taking 
the lead by developing one of the most 
experienced MIS/GI/Thoracic capabilities 
in Philadelphia,” says Dr. Rosato, “and 
are setting the tone and pace for what will 
become the future of general surgery.”
For more information about  
Minimally Invasive Surgery visit: 
www.jeffersonhospital.org/keyhole
Jefferson is also the only hospital 
in the Philadelphia region 
performing a high volume of 
laparoscopic esophagectomies...
“It is truly the generosity 
and the example set forth 
by the Connollys that 
will provide us with the 
resources necessary to fight 
this complicated disease”
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